New MHRA Chief Executive appointed
It has been announced today that Dr Ian Hudson has been appointed as Chief Executive of the Medicines and Healthcare Products Regulatory Agency (MHRA).
The MHRA regulates medicines and medical devices to ensure that they work and are acceptably safe for patients and is an executive agency of the Department of Health.
Dr Hudson is currently the MHRA’s Licensing Director, responsible for the majority of medicines licensing activities. He is the UK delegate to the Committee on Human Medicinal Products (CHMP) at the European Medicines Agency and has been its vice-chairman since October 2012. He will take up the post in September when Sir Kent Woods steps down after ten years with the Agency.
Lord Howe, Health Minister said:
I am delighted to welcome Dr Hudson to his new role. The MHRA carries out vital work to protect the health and well-being of people by ensuring medicines and medical devices work and are acceptably safe.
Dr Hudson is used to working to the highest possible standards and maintaining the very toughest scrutiny over a fast-moving industry and I am confident he will find this role a deeply rewarding challenge.